Hexbyte Glen Cove Two-birds-one-stone strategy shows promise in RNA-repeat expansion diseases thumbnail

Hexbyte Glen Cove Two-birds-one-stone strategy shows promise in RNA-repeat expansion diseases

Alicia Angelbello and Matthew Disney, PhD, in the Disney lab on Scripps Research's Jupiter, Florida, campus. Credit: The Scripps Research Institute A new strategy for treating a variety of diseases known as RNA-repeat expansion disorders, which affect millions of people, has shown promise in proof-of-principle tests conducted by scientists at Scripps Research. The results...

Scroll to top